COST OF MANAGING BLEEDING-RELATED EPISODES (BRE) FOR ROMIPLOSTIM VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO

被引：0
|
作者：
Arocho, R. [1 ]
Northridge, K. [2 ]
Rivera Hurtado, R. [3 ]
Chavez, J. G. [4 ]
机构：
[1] Amgen Inc, Barcelona, Spain
[2] Outcomes Insights Inc, Westlake Village, CA USA
[3] Amgen Mexico, Mexico City, DF, Mexico
[4] Natl Inst Mexico Social Secur IMSS, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1716
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A568 / A569
页数：2
相关论文
共 21 条
  • [1] Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
    Roberto Stasi
    Magaral Murali
    Marc Michel
    Jean-François Viallard
    Aristoteles Giagounidis
    Ann Janssens
    Jason Legg
    Robert Deuson
    Mark D. Danese
    International Journal of Hematology, 2012, 96 : 26 - 33
  • [2] Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
    Stasi, Roberto
    Murali, Magaral
    Michel, Marc
    Viallard, Jean-Francois
    Giagounidis, Aristoteles
    Janssens, Ann
    Legg, Jason
    Deuson, Robert
    Danese, Mark D.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) : 26 - 33
  • [3] Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving Romiplostim or Medical Standard of Care.
    Stasi, Roberto
    Murali, Magaral
    Michel, Marc
    Viallard, Jean-Francois
    Giagounidis, Aristoteles
    Janssens, Ann
    Legg, Jason
    Danese, Mark
    Denson, Robert
    BLOOD, 2009, 114 (22) : 536 - 537
  • [4] BLEEDING-RELATED EPISODES (BRE) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) RECEIVING ELTROMBOPAG (EPAG) OR ROMIPLOSTIM (ROMI): REAL WORLD EVIDENCE FROM 26 US INSTITUTIONS
    Forsythe, A.
    Roy, A.
    Bhor, M.
    Portella, Socorro O. M.
    VALUE IN HEALTH, 2017, 20 (09) : A545 - A545
  • [5] Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials
    Weitz, Ilene Ceil
    Sanz, Miguel A.
    Henry, David H.
    Schipperus, Martin
    Godeau, Bertrand
    Gleeson, Michelle
    Danese, Mark
    Deuson, Robert
    BLOOD, 2009, 114 (22) : 367 - 367
  • [6] A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia
    Weitz, Ilene
    Sanz, Miguel A.
    Henry, David
    Schipperus, Martin
    Godeau, Bertrand
    Northridge, Kelly
    Gleeson, Michelle
    Danese, Mark
    Deuson, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 789 - 796
  • [7] Quality of Life (QOL) in nonsplenectomized Immune Thrombocytopenia (ITP) patients receiving romiplostim or Standard of Care (SOC)
    Rummel, M.
    Kuter, D.
    Mandanas, R.
    Giagounidis, A.
    Wang, X.
    Matthias, S. D.
    Deuson, R.
    ONKOLOGIE, 2011, 34 : 239 - 240
  • [8] EFFICACY AND SAFETY OF ROMIPLOSTIM VERSUS MEDICAL STANDARD OF CARE AS CHRONIC THERAPY FOR NONSPLENECTOMIZED PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Rummel, J.
    Boccia, R.
    Macik, B. G.
    Pabinger, I.
    Selleslag, D.
    Gehl, L.
    Wang, X.
    Berger, D. P.
    Kuter, D. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 425 - 426
  • [9] DETERMINING THE COST OF A BLEEDING-RELATED EPISODE IN PRIMARY ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN THE UNITED STATES
    Northridge, K.
    Danese, M.
    Deuson, R.
    VALUE IN HEALTH, 2013, 16 (03) : A117 - A117
  • [10] Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)
    Wasser, Jeffrey
    Boccia, Ralph Vincent V.
    Lyons, Roger M.
    Mandanas, Romeo
    Pabinger, Ingrid
    Michel, Marc
    Viallard, Jean-Francois
    Wang, Xuena
    Lizambri, Richard
    BLOOD, 2011, 118 (21) : 1411 - 1412
123